INSIGHTS ON CLINICAL TRIAL DESIGN
-
Quotient Sciences Capabilities Update November 2026: Bioavailability And Solubility
Poor solubility can stall promising drugs. See how emerging human PK data can refine formulations, improve exposure, and accelerate development decisions.
-
Navigating The Complex World Of First In Human Oncology Trials
First-in-human oncology trials are critical touchpoints in the development of novel cancer therapies, requiring precise scientific execution and a deeply patient-centric approach.
-
Busting Through Patient Recruitment Barriers
Building patient trust fuels engagement, data and technology enable targeted recruitment, and real-time patient identification with consistent support drives scalable enrollment success.
-
Cutting Corners In RTSM Software Increases Speed...And RISK!
Discover why true RTSM efficiency requires rigor, not shortcuts — highlighting how thoughtful processes and clear communication deliver speed without compromising quality or introducing avoidable risk.
-
Hybrid And Decentralized CNS Clinical Trials: Finding The Right Balance8/24/2026
Decentralized and hybrid trial models are reshaping CNS research. Learn how to match virtual tools to your study design, endpoints, and patient population for better outcomes.
-
Defining Meaningful Anti-Inflammatory Response: What Early Human Data Tells Us9/22/2026
Controlled immune challenges link drug exposure to biological effects, helping refine dose selection, test mechanisms and support better decisions before patient trials.
-
Navigating The Challenges Of Large, International Phase III Breast Cancer Trials5/27/2026
In the competitive landscape of breast cancer research, aligning biomarker testing, regulatory pathways, and regional operations from day one creates a path to faster enrollment and stronger outcomes.
-
The Cell & Gene Unscripted Video Series9/17/2026
Cell and gene therapy is advanced by difficult choices, evolving science, and the people willing to challenge assumptions. This series explores what those decisions mean and what's at stake.
-
Your Biggest Unblinding Risk? Inexperienced Staff4/28/2026
Protect study integrity by closing the gaps in IRT workflows. Learn why rushed communication and training lapses lead to accidental unblinding and how to safeguard your clinical data.
CLINICAL TRIAL DESIGN SOLUTIONS
-
When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.
-
Eliminate manual friction and improve trial visibility with pre-configured, validated workflows. Standardize execution and ensure audit-ready data protection across every global site.
-
Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.
-
Looking to better understand how to solve your organization’s specific clinical trial challenges? In 3 minutes, receive a personalized assessment, with customized results based on a specific role, which will provide a solution-based report curated to your priorities and requirements.
-
Join us in supporting every part of the clinical trial ecosystem — patients, caregivers, sites, and suppliers — to ensure trials run safely, efficiently, and successfully.